The biotechnology industry is one of the fastest growing segments in India. Valued at 11 billion USD in 2018, the Indian biotechnology industry is expected to touch the 100 billion USD mark by 2025, according to the Association of Biotechnology Led Enterprises (ABLE.) With more and more people choosing biotechnology as a career, there is ample chance of success in this field. We will be looking at the biotechnology startups which paved the way for the blooming biotechnology industry in India.
Best Biotechnology Startups In India
1)Biocon
This Bangalore based company is the largest biopharmaceutical company in India. Founded in 1978 with a budget of Rs. 10,000, Biocon started as a company selling the enzyme papain. In the 1990s, founder Kiran Mazumdar-Shaw decided to change the focus of the Company from selling enzymes to selling biopharmaceuticals. Subsequently, Shaw became one of the richest women in India. Today, Biocon sells insulin and monoclonal antibodies, among other products. The Company had an annual revenue of Rs. 4,709 crores in 2018.
2)Sea6 Energy
This startup was founded in 2010 by four IIT Madras graduates and works towards the development of scalable solutions to solve the problem of overconsumption of energy in India. The Company is developing techniques to convert photosynthetic biomass like plants and algae to fuels, in an effort to battle the increasing commercial use of energy in the Country. Incubated at the Centre for Cellular and Molecular Platforms (C-Camp) and funded by the Department of Biotechnology, the startup has patented techniques to facilitate large scale cultivation of selected sea plants.
3)Bharat Biotech
Headquartered at Hyderabad, this Company was founded in 1996 by an Indian scientist, Krishna Ella. One of the leading biopharmaceutical companies in India, Bharat Biotech was the first to develop and patent vaccines for the Zika virus, Zikavac, in the world. It is the first pharmaceutical company to develop a generic drug in India.
4)GANIT Labs
Founded in 2010 in Bangalore by Dr. Vinay Panda and Dr. Vijaya Chandru, Genomics Application and Information Technology Labs (GANIT Labs) is an independent government funded startup. GANIT Labs studies genomes related to oral cancer and helps in mapping their genes. It is also involved in creating analytical tools which effectively analyse and manage large scale genome data, mainly from genome sequencing of disease tissues like cancer.
5)MedGenomes
Founded by Sam Santosh in 2013, MedGenomes provides personalised genetic tests and medicines for a range of ailments like cancer, diabetes and neurological ailments. The Company has headquarters in the U.S.A., and India and claims to operate the largest next gen sequencing lab in southeast Asia. In 2017, the Company secured a whopping Rs. 192 crores in funding. In 2018, MedGenomes was given the MedTech Breakthrough Award for Biomedical Research.
With the growth of the biotechnology industry and a renewed interest of investors in it, the success story of these biotechnology startups will inspire many biotechnology entrepreneurs out there who are aspiring to start their own company one day.
Info Edge (India) Ltd shareholders have overwhelmingly approved an investment of up to ₹1,000 crore in the company’s third venture capital fund, Info Edge Ventures Fund III. The proposal received near-unanimous backing, with 99.9995% of valid votes in favor out of 1,274 participants.
Smartweb Internet Services Ltd, a wholly owned Info Edge subsidiary, will act as sponsor and investment manager for the new fund. This move strengthens Info Edge’s commitment to backing early-stage startups and expanding its footprint in India’s venture capital landscape.
Info Edge has a strong track record as an early investor in leading Indian startups like Zomato and PB Fintech, with combined holdings in these firms valued at ₹31,500 crore ($3.7 billion) as of March 31, 2025.
MeitY Startup Hub (MSH), under the Ministry of Electronics and Information Technology, has partnered with fintech leader Razorpay to support the growth of deeptech and emerging tech startups across India, with a special focus on those in Tier II and III cities. Through this collaboration, early-stage startups will gain access to Razorpay’s fintech infrastructure, mentorship, and resources via the Razorpay Rize program.
Startups in areas like AI, blockchain, robotics, and IoT will benefit from streamlined company incorporation support, expert mentorship, product credits, and guidance for applying to global accelerators such as Y Combinator. Selected founders will also join the exclusive Rize Community, connecting with peer networks and attending masterclasses.
MSH CEO Panneerselvam Madanagopal emphasized that this partnership will help founders scale faster by providing vital support in mentorship, capital access, and digital infrastructure. As India’s startup ecosystem surpasses 159,000 DPIIT-recognised startups, this initiative aims to give deeptech entrepreneurs the tools and networks needed to innovate for India and expand globally.
Info Edge, the parent of Naukri.com, has achieved a 36% gross internal rate of return (IRR) on its startup investments since 2007, turning a total investment of INR 3,959 crore across 111 startups into a portfolio now valued at INR 36,855 crore-a nearly 9X gain. Early bets on Zomato and Policybazaar have been especially lucrative, with holdings in these two companies alone worth INR 31,500 crore as of March 2025.
The company’s investment strategy spans multiple vehicles, including the SEBI-registered Info Edge Venture Fund (IEVF), Info Edge Capital, and Capital 2B, with a combined fund corpus of INR 3,423 crore and Info Edge committing INR 1,614 crore. Early-stage investments now contribute 30-40% of the company’s overall value.
Info Edge’s Alternative Investment Fund (AIF) investments have yielded an IRR of 18.7%. Many portfolio companies, such as TrueMeds, Geniemode, Attentive.ai, and InPrime, have attracted follow-on funding from major investors like Accel, Peak XV Partners, and Tiger Global. Notably, BlueStone, the largest investment of Info Edge Capital, has filed for an IPO after securing investments from Prosus, Peak XV, and Steadview Capital. Founder Sanjeev Bikhchandani emphasized the company’s focus on strong governance and financial controls, with a preference for value realization through public listings or strategic exits.